New drug candidates for treatment of atypical meningiomas: An integrated approach using gene expression signatures for drug repurposing. (2018)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1371/journal.pone.0194701
PubMed Identifier: 29558515
Publication URI: http://europepmc.org/abstract/MED/29558515
Type: Journal Article/Review
Volume: 13
Parent Publication: PloS one
Issue: 3
ISSN: 1932-6203